James McGovern (D-MA)
Recognizing the history of the drug diethylstilbestrol and the harm it has caused, and for other purposes.
A Democratic resolution with no cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.
What this bill would do
This resolution recognizes the history and harm caused by the drug diethylstilbestrol, known as DES. DES was approved by the Food and Drug Administration in the early 1940s and widely given to pregnant women until 1971 to prevent miscarriage. Exposure to DES has been linked to rare cancers, fertility and pregnancy complications, and other health challenges. The Food and Drug Administration banned its use during pregnancy in 1971 and has acknowledged the harm caused, but has not yet apologized. This measure supports designating a DES Awareness Week, recognizing the harm caused, restoring funding for the DES Follow-Up Study, and urging the Food and Drug Administration to issue a formal apology.
Yes· 3 of 8
- Scored +4
Does this put more money into medical research?
The resolution explicitly supports the restoration of funding for the DES Follow-Up Study.
- Scored +3
Would people over 65 be better off under this?
The resolution directly recognizes the long-term health challenges faced by older individuals and families impacted by DES use decades ago.
- Scored +3
Would women be better off under this?
The resolution brings awareness and support to women and families who experienced reproductive health complications due to DES exposure.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
DES Awareness Week Support: Under Resolved, (1), the House of Representatives expresses support for designating ``DES Awareness Week'' from April 20 through 26, 2025, which brings attention to the history and health impacts of the drug.
-
Recognition of Harm: Under Resolved, (2), the resolution recognizes the history of the drug and the harm it has caused to individuals and families.
-
Study Funding: Under Resolved, (3), the resolution supports the restoration of funding for the DES Follow-Up Study, which could help track and understand health challenges related to the drug.
-
Call for Apology: Under Resolved, (4), the measure urges the Food and Drug Administration to issue a formal apology to the families impacted by diethylstilbestrol.
Potential Negative Impacts for People
- No Negative Impacts Identified: The provided text of the resolution does not contain any specific sections or provisions that outline negative consequences, burdens, or harms for individuals or groups of people in the United States.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would people over 65 be better off under this? — The resolution directly recognizes the long-term health challenges faced by older individuals and families impacted by DES use decades ago. Would women be better off under this? — The resolution brings awareness and support to women and families who experienced reproductive health complications due to DES exposure. Would retired people be better off under this? — Retirees who were exposed to DES or whose families were impacted receive recognition and advocacy through this resolution.
- Healthcare
- Does this put more money into medical research? — The resolution explicitly supports the restoration of funding for the DES Follow-Up Study. Does this make health care easier to get in general? — The resolution supports restoring funding for the DES Follow-Up Study to better track health impacts related to the drug.
- Education And Technology
- Does this put more money into scientific research? — The resolution supports the restoration of funding for the DES Follow-Up Study, benefiting ongoing medical research.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The measure encourages federal accountability by urging the FDA to formally acknowledge and apologize for past harms.
- Social Issues And Justice
- Does this narrow the gap between how men and women are treated? — The resolution brings awareness to the historical health harms disproportionately suffered by women prescribed DES during pregnancy and their offspring.
- 4/21/2025
- Submitted in House
- Referred to the House Committee on Energy and Commerce.